News from NYU Langone Health
NYU Langone Expands In Suffolk County With New Ambulatory Facility – Surgery Center To Follow. (ANCA Vasculitis News)
(5/28) NYU Langone Health opened a new ambulatory care facility in Westhampton Beach, New York, offering primary care, cardiology, and endocrinology services, with construction underway on a six-operating-room ambulatory surgery center in Patchogue expected to open in 2026, with Andrew W. Brotman, MD, executive vice president, vice dean and chief clinical officer for clinical affairs and strategy, and professor, Department of Psychiatry, saying in a press release, “This facility underscores our commitment to patients in Suffolk County and our mission of bringing world-class care closer to where patients live and work.” Vicki Match Suna, AIA, executive vice president and vice dean for real estate development and facilities, said, “As with all our new locations, our design approach prioritizes the patient experience, creating a comfortable and welcoming environment,” adding that it “aligns with Westhampton’s architectural style and draws inspiration from its surrounding coastlines.”
NYU Langone Health Plans $22M Coronary Care Expansion. (Becker's Hospital Review)
(5/29) NYU Langone Health filed a certificate of need with the New York State Department of Health on May 23, requesting nearly $22 million to construct eight permanent coronary care rooms on the fourth floor of NYU Langone Hospital–Brooklyn, converting seven existing temporary coronary care beds into acute medical and surgical rooms upon completion.
Can Gene-Edited Pigs Solve The Organ Transplant Shortage? (Science)
(5/29) NYU Langone Health surgeons transplanted a genetically modified pig kidney into Towana Looney, marking a milestone in xenotransplantation, with her kidney functioning well for 130 days before failure, while Timothy Andrews, who also received a pig kidney, continues to do well; Looney’s transplant was part of a growing effort to address human organ shortages through pig organs, with United Therapeutics and eGenesis planning further clinical trials; Robert Montgomery, MD, DPhil, the H. Leon Pachter MD Professor of Surgery, and chair, Department of Surgery, Transplant Institute, who performed Looney’s surgery, saying, “This is really a victory,” despite Looney’s eventual return to dialysis.
Shoulder Inflammation Hampering Key Yankees Hurler. (New York Post)
The (5/29) “Guillem Gonzalez-Lomas, MD, assistant professor, Department of Orthopedic Surgery, joins Brandon London for the weekly ‘Injury Report’ segment to provide insight into the shoulder inflammation that’s afflicting Yankees reliever Fernando Cruz.”
Study: Treating Hearing Loss Can Reduce Social Isolation In Seniors. (Hearing Review)
(5/29) A study led by NYU Langone Health as part of the ACHIEVE clinical trial found that older adults using hearing aids and receiving personalized audiology support maintain more diverse and meaningful social connections, potentially reducing loneliness, with the research showing that treated individuals retained more social connections over three years compared to those without interventions; study lead author Nicholas S. Reed, MD, Departments of Otolaryngology-Head and Neck Surgery, and Population Health, Optimal Aging Institute, said, “Our findings add to evidence that helping aging patients hear better can also enrich their social lives and boost their mental and physical well-being,” while Josef Coresh, MD, PhD, the Terry and Mel Karmazin Professor of Population Health, Department of Population Health, professor, Department of Medicine, Optimal Aging Institute, emphasized the importance of Medicare coverage for hearing aids to combat social isolation among seniors.
Youth Deaths Attributable To Synthetic Opioids Alone Increasingly Predominant. (HealthDay)
(5/29) reports that a study published on May 20 in Pediatrics conducted by Megan Miller, MPH, research coordinator, Center for Opioid Epidemiology and Policy, indicates overdose deaths among 15 to 24-year-olds increased from 4,652 to 6,723 between 2018 to 2022; the rate of synthetic opioid-only deaths rose from 1.8 to 4.8 per 100,000.
Removing One Amino Acid From The Diet Sparks Dramatic 30% Weight Loss In One Week. (GB News (UK))
(5/29) Researchers at NYU Grossman School of Medicine, including co-senior study author Evgeny A. Nudler, PhD, the Julie Wilson Anderson Professor of Biochemistry, Department of Biochemistry and Molecular Pharmacology, have discovered a potential metabolic “kill switch” for weight loss, where genetically modified mice lost 30% of their body weight in a week by eliminating the amino acid cysteine from their diet, triggering rapid fat loss through interconnected biological pathways.
Study Links Belly Fat To Psoriasis. (WNYW-TV New York)
(5/29) Devi E. Nampiaparampil, MD, clinical associate professor, Department of Rehabilitation Medicine, discussed a study linking belly fat to psoriasis, suggesting a stronger connection between the skin condition and obesity, particularly in women, which may involve inflammation and gut-related issues; she also addressed a New York study identifying pizza, soup, and chicken as top salt sources in American diets, emphasizing the health risks of high salt intake, particularly for individuals sensitive to salt, which can lead to high blood pressure, heart disease, and stroke.
Dealing With Constipation? You Likely Have This Tried-And-True Remedy At Home. (Women's Health)
(5/29) Lisa Ganjhu, DO, clinical professor, Department of Medicine, Division of Gastroenterology and Hepatology, advises addressing constipation within two to three days and suggests incorporating water, probiotics, leafy greens, and high-fiber fruits into the diet.
News from NYU Langone Hospital—Brooklyn
Can This FDA-Approved Drug Tame Hot Flashes And Menopause Belly? (Flowspace)
(5/29) A recent study on fezolinetant, a non-hormonal treatment for moderate to severe hot flashes in menopausal women, reveals that it may also help reduce weight and waist circumference without specific dietary or exercise interventions; Meleen Chuang, MD, clinical associate professor, and chief, Department of Obstetrics and Gynecology, Family Health Centers—Brooklyn, explained that “Fezolinetant is a neurokinin-3 (NK3) receptor blocker” that alleviates menopause symptoms and may encourage healthier lifestyle choices, offering hope for personalized menopause management.
News from NYU Langone Hospital—Long Island
Garden City Dermatologist Who Survived Skin 鶹Ƶapp Offers Tips. (Newsday (NY))
(5/30) Nicole M. Golbari, MD, MPH, clinical associate professor, Department of Medicine—Long Island, shares her personal experience with melanoma to connect with patients, advising them on skin cancer prevention, such as using cellphone photos to track moles and reapplying sunscreen with at least SPF 30, while also dispelling myths that melanoma predominantly affects older white men, emphasizing its risk to people with darker skin types, and stressing that “there is no safe tan.”
